ADVFN Logo ADVFN

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Dati di Mercato
Notizie
Utensili
Mercato
Scoprire

Caratteristiche principali

Follow Feed

Connettiti con trader e investitori nella nostra comunità Follow Feed.

Flusso di Opzioni

Esplora i dati completi sulle opzioni e utilizza filtri avanzati con Options Flow.

Monitor

Organizza e monitora la tua watchlist di azioni e attività con Monitor.
Accedi/Registrati Premium IconPremium Help Menu
Ftse Mib
39.187,53
-1,32%
DAX
22.970,51
-1,42%
S&P 500
5.702,12
0,47%
NASDAQ
17.881,55
0,74%
Bitcoin
86.041,29
-0,98%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati
  1. Home
  2. Investire
  3. Azioni
  4. U.S.A.
  5. NASDAQ
  6. Terns Pharmaceuticals Inc (TERN)

  7. Terns Pharmaceuticals Inc (TERN) Notizie

TERN

Terns Pharmaceuticals (TERN)

Terns Pharmaceuticals Inc
Da:
Ordina per:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:TERN
DataOraFonteTitoloSimboloCompagnia
26/02/202522:05GlobeNewswire Inc.Terns Pharmaceuticals Reports Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:TERNTerns Pharmaceuticals Inc
25/02/202514:05GlobeNewswire Inc.Terns Pharmaceuticals Provides Program Updates and Announces Participation at TD Cowen 45th Annual Healthcare ConferenceNASDAQ:TERNTerns Pharmaceuticals Inc
24/02/202522:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TERNTerns Pharmaceuticals Inc
24/02/202522:05GlobeNewswire Inc.Terns Pharmaceuticals Appoints Andrew Gengos as Chief Financial OfficerNASDAQ:TERNTerns Pharmaceuticals Inc
20/02/202522:05GlobeNewswire Inc.Terns Pharmaceuticals Appoints Robert Azelby to Board of DirectorsNASDAQ:TERNTerns Pharmaceuticals Inc
05/02/202523:28Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:TERNTerns Pharmaceuticals Inc
05/02/202522:05GlobeNewswire Inc.Terns Pharmaceuticals to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences ConferenceNASDAQ:TERNTerns Pharmaceuticals Inc
04/02/202501:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TERNTerns Pharmaceuticals Inc
03/02/202522:05GlobeNewswire Inc.Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:TERNTerns Pharmaceuticals Inc
08/01/202522:05GlobeNewswire Inc.Terns Pharmaceuticals to Present at 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:TERNTerns Pharmaceuticals Inc
03/12/202413:00GlobeNewswire Inc.Terns Pharmaceuticals Announces Positive Early Data from Phase 1 CARDINAL Trial of TERN-701 for Chronic Myeloid LeukemiaNASDAQ:TERNTerns Pharmaceuticals Inc
18/11/202422:05GlobeNewswire Inc.Terns Pharmaceuticals Appoints Heather Turner, J.D., to Board of DirectorsNASDAQ:TERNTerns Pharmaceuticals Inc
12/11/202423:06Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TERNTerns Pharmaceuticals Inc
12/11/202422:45Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TERNTerns Pharmaceuticals Inc
12/11/202422:05GlobeNewswire Inc.Terns Pharmaceuticals Reports Third Quarter 2024 Financial Results and Corporate UpdatesNASDAQ:TERNTerns Pharmaceuticals Inc
06/11/202422:05GlobeNewswire Inc.Terns Pharmaceuticals to Participate in Upcoming November Investor ConferencesNASDAQ:TERNTerns Pharmaceuticals Inc
24/10/202420:02Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:TERNTerns Pharmaceuticals Inc
13/09/202401:00GlobeNewswire Inc.Terns Announces Closing of Public Offering of Shares of Common Stock and Pre-Funded Warrants, Including Full Exercise of Underwriters’ Option to Purchase Additional SharesNASDAQ:TERNTerns Pharmaceuticals Inc
11/09/202422:09Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:TERNTerns Pharmaceuticals Inc
11/09/202404:50GlobeNewswire Inc.Terns Announces Pricing of Upsized $150.15 Million Public OfferingNASDAQ:TERNTerns Pharmaceuticals Inc
09/09/202422:01GlobeNewswire Inc.Terns Announces Proposed Public OfferingNASDAQ:TERNTerns Pharmaceuticals Inc
09/09/202413:05GlobeNewswire Inc.Terns Pharmaceuticals Announces Positive Phase 1 Clinical Trial Results with TERN-601 Once-Daily Oral GLP-1R Agonist for the Treatment of ObesityNASDAQ:TERNTerns Pharmaceuticals Inc
05/08/202422:05GlobeNewswire Inc.Terns Pharmaceuticals Reports Second Quarter 2024 Financial Results and Corporate UpdatesNASDAQ:TERNTerns Pharmaceuticals Inc
29/07/202422:05GlobeNewswire Inc.Terns Pharmaceuticals Appoints Biotech Executive Elona Kogan as Chief Legal Officer and Announces Upcoming CFO TransitionNASDAQ:TERNTerns Pharmaceuticals Inc
22/06/202400:30GlobeNewswire Inc.Terns Pharmaceuticals Highlights New Preclinical Data Supporting TERN-501 in Combination with a GLP-1R Agonist for Obesity at the ADA’s 84th Annual Scientific Sessions and Upcoming Conference ParticipationNASDAQ:TERNTerns Pharmaceuticals Inc
03/06/202422:10GlobeNewswire Inc.Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:TERNTerns Pharmaceuticals Inc
30/05/202414:05GlobeNewswire Inc.Terns Pharmaceuticals to Participate in Upcoming June Investor ConferencesNASDAQ:TERNTerns Pharmaceuticals Inc
17/05/202422:05GlobeNewswire Inc.Terns Pharmaceuticals to Participate in UBS Obesity Therapeutics DayNASDAQ:TERNTerns Pharmaceuticals Inc
13/05/202414:05GlobeNewswire Inc.Terns Pharmaceuticals Reports First Quarter 2024 Financial Results and Corporate UpdatesNASDAQ:TERNTerns Pharmaceuticals Inc
08/05/202422:05GlobeNewswire Inc.Terns Pharmaceuticals Announces Leadership ChangesNASDAQ:TERNTerns Pharmaceuticals Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:TERN

La tua Cronologia

BOV
CSRN6F
COSERN PNB
BOV
RCSL3F
RECRUSUL ON
BOV
FRTA3R
POMIFRUTAS ON
BOV
BTLT39
BlackRock Institutional ...
NYSE
NREF
NexPoint Real Estate Fin...
BOV
BECH39
BlackRock Institutional ...
BITMOT
2707269
Rentenbank Fx 5% Oct33 Usd
BOV
BEDC39Q
Global X Funds
EU
NGASP
WisdomTree Commodity Sec...
UNSW3
MNTOUSDT
Minato
BOV
USIM5M
USIMINAS PNA
COIN
SAMUSD
SAMURAI
BIT
SFER
Salvatore Ferragamo
AMEX
DUG
ProShares UltraShort Ene...
NYSE
DAN
Dana
NYSE
SHO
Sunstone Hotel Investors
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Italia
Azienda
Attività
Popular
Ottieni l'app
App Store
Google Play

Assistenza: help@advfn.com

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

© 2025 ADVFN PLC - Tutti i diritti riservati

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci